{
  "id": "6450f1b457b1c7a315000092",
  "type": "summary",
  "question": "What is Kearns-Sayre syndrome (KSS)?",
  "ideal_answer": "Kearns-Sayre Syndrome (KSS) is a rare mitochondrial disease characterized by a primary dysfunction of the mitochondrial respiratory chain. It is a rare mitochondrial disorder with a triad of features, including progressive external ophthalmoplegia, pigmentary retinopathy, and an alteration of cardiac conduction. KSS is a rare, multisystem mitochondrial encephalomyopathy.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/36181358",
    "http://www.ncbi.nlm.nih.gov/pubmed/16735969",
    "http://www.ncbi.nlm.nih.gov/pubmed/9727847",
    "http://www.ncbi.nlm.nih.gov/pubmed/26884075",
    "http://www.ncbi.nlm.nih.gov/pubmed/22981519",
    "http://www.ncbi.nlm.nih.gov/pubmed/22875312",
    "http://www.ncbi.nlm.nih.gov/pubmed/25539952",
    "http://www.ncbi.nlm.nih.gov/pubmed/9509412",
    "http://www.ncbi.nlm.nih.gov/pubmed/15869681",
    "http://www.ncbi.nlm.nih.gov/pubmed/9677732",
    "http://www.ncbi.nlm.nih.gov/pubmed/35477912",
    "http://www.ncbi.nlm.nih.gov/pubmed/9286453",
    "http://www.ncbi.nlm.nih.gov/pubmed/22231766",
    "http://www.ncbi.nlm.nih.gov/pubmed/1638160",
    "http://www.ncbi.nlm.nih.gov/pubmed/35795638",
    "http://www.ncbi.nlm.nih.gov/pubmed/572507",
    "http://www.ncbi.nlm.nih.gov/pubmed/11018246",
    "http://www.ncbi.nlm.nih.gov/pubmed/35031921",
    "http://www.ncbi.nlm.nih.gov/pubmed/16773512",
    "http://www.ncbi.nlm.nih.gov/pubmed/16977556",
    "http://www.ncbi.nlm.nih.gov/pubmed/17763890",
    "http://www.ncbi.nlm.nih.gov/pubmed/35721635",
    "http://www.ncbi.nlm.nih.gov/pubmed/7946321",
    "http://www.ncbi.nlm.nih.gov/pubmed/10465502",
    "http://www.ncbi.nlm.nih.gov/pubmed/27442316",
    "http://www.ncbi.nlm.nih.gov/pubmed/12007693",
    "http://www.ncbi.nlm.nih.gov/pubmed/1424198",
    "http://www.ncbi.nlm.nih.gov/pubmed/7630231",
    "http://www.ncbi.nlm.nih.gov/pubmed/31158487",
    "http://www.ncbi.nlm.nih.gov/pubmed/19344916",
    "http://www.ncbi.nlm.nih.gov/pubmed/25368789",
    "http://www.ncbi.nlm.nih.gov/pubmed/33030289",
    "http://www.ncbi.nlm.nih.gov/pubmed/32609007",
    "http://www.ncbi.nlm.nih.gov/pubmed/27709644",
    "http://www.ncbi.nlm.nih.gov/pubmed/25061332",
    "http://www.ncbi.nlm.nih.gov/pubmed/32787478",
    "http://www.ncbi.nlm.nih.gov/pubmed/17342029",
    "http://www.ncbi.nlm.nih.gov/pubmed/23102393",
    "http://www.ncbi.nlm.nih.gov/pubmed/9832255",
    "http://www.ncbi.nlm.nih.gov/pubmed/16735000",
    "http://www.ncbi.nlm.nih.gov/pubmed/29416473",
    "http://www.ncbi.nlm.nih.gov/pubmed/26949540",
    "http://www.ncbi.nlm.nih.gov/pubmed/35073857"
  ],
  "snippets": [
    {
      "text": "Kearns Sayre Syndrome (KSS) is a rare mitochondrial disease characterized by a primary dysfunction of the mitochondrial respiratory chain. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35795638",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome is a rare mitochondrial disorder. It had a triad of features, including progressive external ophthalmoplegia, pigmentary retinopathy, and an alteration of cardiac conduction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35721635",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a rare, multisystem mitochondrial encephalomyopathy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35073857",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS), first described in 1958, is a multisystem disease defined by a characteristic triad of progressive external ophthalmoplegia, pigmentary retinopathy and atrioventricular block.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22981519",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "KSS is a mitochondrial disorder that occurs rarely; the actual incidence is unknown.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1638160",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Kearns-Sayre syndrome (KSS) is a distinctive type of progressive external ophthalmoplegia, characterized by pigmentary degeneration of the retina, heart block, elevated concentration of cerebrospinal fluid protein, and abnormal muscle mitochondria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/572507",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a form of mitochondrial myopathy in which specific clinical features, namely progressive external ophthalmoplegia, pigmentary retinal degeneration and cardiac conduction defects, occur.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1424198",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "UNLABELLED: Kearns-Sayre syndrome (KSS) is a rare mitochondrial DNA deletion syndrome defined as the presence of ophthalmoplegia, pigmentary retinopathy, onset less than age 20 years, and one of the following: cardiac conduction defects, cerebellar syndrome, or cerebrospinal fluid protein abov",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22875312",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre Syndrome is form of rare mitochondrial cytopathy, first described by Thomas P. Kearns and George Pomeroy Sayre in 1958 and is characterized by progressive external opthalmoplegia, cardiac conduction block, pigmentary retinal degeneration, variable number of red ragged fibers on muscle biopsy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22231766",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a mitochondrial encephalomyopathy characterized by progressive external ophthalmoplegia (PEO), pigmentary retinopathy and onset before the age of 20 years.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16735000",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns Sayre syndrome (KSS) is a mitochondrial disorder characterized by the emergence before age 20 of progressive external ophthalmoplegia, pigmentary retinopathy, together with other heterogeneous clinical manifestations, including cardiac conduction defects, muscle abnormalities and endocrinopathies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16735969",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a mitochondrial disorder.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9677732",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a sporadic multisystem disorder due to a defect of oxidative phosphorylation and associated with clonally-expanded rearrangements of mitochondrial DNA (mtDNA) deletions (Delta-mtDNAs) and/or duplications (dup-mtDNAs).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11018246",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: Kearns-Sayre syndrome (KSS) is a mitochondrial disorder characterized by progressive external ophthalmoplegia, pigmentary retinopathy, onset before 20 years, and ragged-red fibers on ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16977556",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a progressive neuromuscular disease characterized by ophthalmoplegia, cardiac conduction block, and pigmentary retinopathy associated with abnormal mitochondrial structure and function.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9832255",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a rare syndrome characterized by the triad of progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction system disturbances; it is a mitochondrial encephalomyopathy with which usually presents before the patient reaches the age of 20.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23102393",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre Syndrome (KSS) is a subtype of chronic progressive external ophthalmoplegia (CPEO).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35477912",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) was first described in 1958 as 'a rare neuromuscular disorder defined by a characteristic triad of progressive external ophthalmoplegia, pigmentary retinopathy, atrioventricular block and cerebellar ataxia'.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26949540",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "scribed. Kearns-Sayre syndrome (KSS) is a mitochondrial disorder characterized by retinitis pigmentosa, external ophthalmoplegia, and hea",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27442316",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a multisystem mitochondrial disorder characterized by the invariant triad: onset before 20, progressive external ophthalmoplegia and pigmentary retinal degeneration, plus at least one of the following: complete (or not) heart block, cereberal dysfunction and CSF protein above 100 mg/dl.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12007693",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " This has lead to increasing interest in the contribution which mtDNA deletions make to Kearns-Sayre Syndrome (KSS) and other disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17342029",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is the most commonly diagnosed mitochondrial myopathy and it produces severe neuromuscular symptoms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9509412",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a disease with severe clinical symptoms that often arises from a mitochondrial DNA deletion of 4977 bp.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7946321",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a disorder caused by mutations in mitochondrial DNA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27709644",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a rare genetic abnormality.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15869681",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a rare mitochondrial myopathy that usually develops before 20 years of age.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25368789",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a rare mitochondrial DNA (mtDNA) deletion syndrome that typically presents before 20\u00a0years of age and is characterized by chronic progressive external ophthalmoplegia, pigmentary retinopathy, and a combination of cardiac conduction defects, cerebellar ataxia, and elevated cerebrospinal fluid protein levels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31158487",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS), a rare form of mitochondrial myopathy, is a triad of chronic progressive external ophthalmoplegia, bilateral pigmentary retinopathy, and cardiac conduction abnormalities.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29416473",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns-Sayre syndrome (KSS) is a sporadic multisystem disorder due to rearrangements in mitochondrial DNA (mtDNA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10465502",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kearns Sayre Syndrome (KSS) is a rare mitochondrial disease characterized by a primary dysfunction of the mitochondrial respiratory chain.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35795638",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "UNLABELLED: Kearns Sayre syndrome (KSS) is a multisystem disorder with a confounding variety of clinical manifestations, including ocular myopathy, pigmentary retinopathy, heart block and ataxia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9727847",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "UNLABELLED: Kearns-Sayre syndrome (KSS) is a rare mitochondrial DNA deletion syndrome defined as the presence of ophthalmoplegia, pigmentary retinopathy, onset less than age 20 years, and one of the following: cardiac conduction defects, cerebellar syndrome, or cerebrospinal fluid protein above 100 mg/dl",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22875312",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Kearns-Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20\u2009years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36181358",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}